This will be less than $25 by year's end... on same terms.
We go to triple digits by year end.
The low value of SQNM does not make sense to me, nor does its high short position. Many companies are cash and stock rich. SQNM could easily be acquired in a blink of an eye. I see the same in MNKD. Just weeks away from potential FDA approval and yet only 18% institution interest and a huge short position. I do not get it.
Khol's is way overpriced and it has everything to lose. JCP is a much better place to shop in store and online.
the best is yet to come. we came a long way but there is plenty more to go. no reason why the 30s shouldn't hold. look at ICPT, a very long way to go and up huge on speculation. ACAD is far beyond speculative.
MNKD has been tanking since $8 with something so promising on the near horizon. I would expect it to run like ACAD did this past week. The shorts no reason to cover as institutions aren't pouring in to take a position.
Of course it takes time. We are seeing results which further removes the fear of BK. After all, the lenders want to get paid. Upside potential is huge. Shorts did great riding it down to $4.9 but they'd have to be insane not to cover.